Click here for coronavirus updates Pandemic Pass or Fail

KU Medical Center part of COVID-19 clinical trial


KANSAS CITY, Kan. (AP) — The University of Kansas Medical Center is part of a nationwide clinical trial looking into different treatments for patients with mild to moderate symptoms of the coronavirus who do not require hospitalization.

KCUR-FM reports that the first treatment will involve the use of monoclonal antibodies that target the spike proteins of COVID-19, using a drug made by Eli Lilly.

Monoclonal antibodies are engineered versions of the same virus-fighting antibodies that the body naturally produces.

The clinical trial is one of at least 40 around the country that seeks to recruit participants within 10 days of the onset of symptoms or within seven days of a positive test.


Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Download the KSN News App and stay up-to-date wherever you are. You can even watch KSN News live for free!
Click here to get the app
Get it in the App store
Get it in the Google Play store

3 Day Forecast

KSN Storm Track 3 Weather

Trending Stories